Description | The antibody S-B8 is a human mAb specific for SARS-CoV-2 Spike S1 protein. It competes strongly with hACE2-ECD in a dose-dependent manner, with IC50 value of 12.9 ± 1.5 nM. It exhibits apparent KD value of 7.79 nM. It binds the receptor binding site (RBS) and sterically compete with ACE2 for RBD binding. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | SARS-CoV-2 |
Epitope | Receptor-binding domain (RBD) |
Affinity | 7.79 nM |
Isotype | IgG1 |
Expression Species | HEK293F or CHO cell line |
Conjugation | Unconjugated |
Purity | >95% |
Endotoxin | <1 EU/mg |
Form | Liquid |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
Application | ELISA, Neut |
Application Notes | The IC50 value of S-B8 is 12.9 ± 1.5 nM. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Western Blot Protocol |
Target | SARS-CoV-2 |
Alternative Name | Severe acute respiratory syndrome coronavirus 2 |
Research Area | Coronavirus Disease 2019 |
Related Disease | Coronavirus Disease 2019 |